Pharma Journalist 9038 posts 0 comments

GlycoMimetics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the Company a Rare Pediatric Disease designation for rivipansel for the treatment of sickle…
Read More...

Eureka Therapeutics, Inc., a clinical stage biotechnology company developing novel T cell therapies to treat solid tumors, today announced the Company has initiated a Phase I/II…
Read More...

SpringWorks Therapeutics, Inc. announced that the company has entered into a clinical trial collaboration agreement with Pfizer Inc. (NYSE: PFE) to evaluate SpringWorks Therapeutics’…
Read More...

Nimble Therapeutics Inc. announced the company has entered into a strategic collaboration with Incyte to discover first-in-class peptide therapies across various disease areas. “This…
Read More...

Bristol Myers Squibb and MyoKardia, Inc. announced a definitive merger agreement under which Bristol Myers Squibb will acquire MyoKardia for $13.1 billion, or $225.00 per share in cash.…
Read More...

NVIDIA announced a partnership with global healthcare company GSK and its AI group, which is applying computation to the drug and vaccine discovery process. GSK has recently…
Read More...

World ADC is pleased to publish the winners of the 7th Annual World ADC Awards, held at World ADC Digital in September. The World ADC Awards reward the innovation, leadership, and…
Read More...

SMi Reports: Renowned industry experts from MedinCell and Janssen to present on the Pre-Filled Syringes and Injectable Drug Devices pre-conference workshop taking place 12th January…
Read More...

BONE THERAPEUTICS, the cell therapy company addressing unmet medical needs in orthopedics and other diseases, Link Health Pharma Co., Ltd and Shenzhen Pregene Biopharma Company, Ltd…
Read More...

Bristol Myers Squibb announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the…
Read More...